August 2011 Newsletter

August 25, 2011:

US Refractive Surgery Market Still Sputtering

US refractive procedure volume rose in Q2-2011 but failed to meet expectations, paralleling continued weakness in the US economy and spurring a downward revision of our forecast.

August 25, 2011:

Increases in US IVT Injections Slowed in Q2-2011

Q2-2011’s survey of retina specialists indicates a slowing of the significant growth in IVT injections that has been experienced in recent quarters. Vitrectomy numbers edged up, while laser photocoagulation and PDT procedures further declined.

August 25, 2011:

FDA Decision on Eylea (VEGF Trap-Eye) Postponed

In June, Eylea received a unanimous recommendation for market approval from the FDA’s Dermatologic and Ophthalmic Drugs Advisory Committee.

August 25, 2011:

2011 Ophthalmic Diagnostic Equipment Market Expected to Reach $2.3 Billion

More than 470 ophthalmic diagnostic products are expected to generate $2.3 billion in revenue this year. Our 2011 Comprehensive Report on the Global Ophthalmic Diagnostic Equipment Market will be released by the end of the summer.

August 25, 2011:

IOL Companies Hope to Reclaim US NTIOL Status

IOL companies are currently trying to reinvigorate the new technology IOL (NTIOL) designation based on several claims.

August 25, 2011:

August 2011 News Briefs

This month's news includes the latest from PowerVision, Abbott Medical Optics, ISTA Pharmaceuticals, Merge Healthcare and Ophthalmic Imaging Systems.

Social media